🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, multinational, double-blind, 1:1 randomized, paralle...
Status
Completed
Location
MedRadius
Start Date
2018-02-06
Trial ID
NCT03296163
Treatments Being Tested
This study is a Phase 1 Randomized, Double-blind, Three-arm, Parallel Group...
Status
Completed
Location
Inje University Busan Paik Hospital
Start Date
2017-08-07
Trial ID
NCT03247673
Treatments Being Tested
This is a Phase 1, open-label, single-center, dose-escalation study evaluat...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-01-01
Trial ID
NCT07729098
Treatments Being Tested
This phase II clinical trial studies how well ERC1671 plus Granulocyte-macr...
Status
Unknown
Location
University of California, Irvine
Start Date
2014-03
Trial ID
NCT01903330
This study is a first-in-human, Phase 1a/1b, multicenter, open-label study ...
Status
Terminated
Location
Mayo Clinic
Start Date
2020-09-23
Trial ID
NCT04553692
A Randomised, Double Blind, Two-Arm, Single Dose, Parallel Phase I Study To...
Status
Completed
Location
SOUSEIKAI Hakata Clinic
Start Date
2019-08-02
Trial ID
NCT04238650
Treatments Being Tested
Randomized, double blind, parallel group, single dose, 3 arm study to inves...
Status
Completed
Location
Early Phase Clinical Unit (EPCU) PAREXEL International GmbH
Start Date
2019-09-24
Trial ID
NCT04238663
Treatments Being Tested
This is a 12-week, randomized, double-blind, single-dose pharmacokinetic (P...
Status
Completed
Location
WCCT Global, Inc.
Start Date
2018-06-12
Trial ID
NCT03882424
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of transar...
Status
Completed
Location
Gao-Jun Teng
Start Date
2022-12-28
Trial ID
NCT05332821
Treatments Being Tested
Randomized, double blind, parallel group, single dose, 3 arm study to inves...
Status
Completed
Location
PAREXEL International - Northwick Park Hospital
Start Date
2017-12-07
Trial ID
NCT03293654
Treatments Being Tested